Content about Haemophilia

January 7, 2013
Biogen Idec hopes treatment will be first advance in hemophilia B treatment in 15 years

Biogen Idec is seeking Food and Drug Administration approval for a hemophilia drug that it called the first of its kind.

November 28, 2012
Novo Nordisk app designed to help hemophilia patients, families

Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.

July 9, 2012
BioRx acquires Minn. bleeding-disorder pharmacy

Specialty pharmacy provider BioRx has acquired another specialty pharmacy provider based in Minnesota, BioRx said Monday.

May 29, 2012
BioPlus promotes Shelley Moore to lead bleeding disorders program

BioPlus Specialty Pharmacy has appointed a new person to head its bleeding disorders program, the company said Tuesday.

January 12, 2012
Octapharma USA hires former Baxter BioScience executive

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

April 28, 2011
Bayer extends sponsorship agreement with World Federation of Hemophilia

Bayer HealthCare Pharmaceuticals and the World Federation of Hemophilia announced Thursday a three-year extension of Bayer’s sponsorship agreement with the WFH.

April 26, 2011
FDA OKs storage option for Kogenate FS

The Food and Drug Administration has approved a new storage option for a hemophilia A treatment made by Bayer HealthCare Pharmaceuticals, the drug maker said.

April 8, 2011
Novo Nordisk honored by National Hemophilia Foundation

Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.

March 21, 2011
MedPro Rx announces Education Is Power scholarship program

Patients with bleeding disorders could be eligible for a scholarship from a specialty pharmacy provider that specializes in treating them.

February 24, 2011
Novo Nordisk develops treatment for rarest bleeding disorder, seeks FDA approval

Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.

October 31, 2010
Octapharma USA starts phase 3 trial for hemophilia treatment

The U.S. subsidiary of a Swiss biotech company has started a late-stage trial of a...

August 15, 2010
Pfizer's Xyntha-administering syringe gets FDA approval

The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for...

August 10, 2010
FDA approves additional dosage for NovoSeven RT

The Food and Drug Administration has approved a new dose of a treatment for hemophilia...

June 27, 2010
Bayer launches mobile app for hemophilia patients

Bayer HealthCare Pharmaceuticals has launched a free mobile application for patients with hemophilia, the drug...

January 24, 2010
Bayer to halt phase 2 trial of hemophilia treatment

Bayer Schering Pharma will halt a mid-stage clinical trial of an investigational treatment for hemophilia,...

January 20, 2010
Ipsen, Inspiration Pharmaceuticals to develop hemophilia franchise

Despite its rarity, occurring in 1-in-5,000 to 1-in-25,000 male births, hemophilia can be a debilitating...

January 17, 2010
MedPro Rx offering scholarships to students with bleeding disorders

Prospective college students living with bleeding disorders have a chance to receive a scholarship from...

© 2013 Drug Store News. All Rights Reserved.